These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30818928)

  • 21. Internal jugular vein sampling in adrenocorticotropic hormone-dependent Cushing's syndrome: a comparison with inferior petrosal sinus sampling.
    Erickson D; Huston J; Young WF; Carpenter PC; Wermers RA; Bonelli FS; Powell CC
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):413-9. PubMed ID: 15049954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of bilateral inferior petrosal sinus sampling in the diagnosis and surgical treatment of the ACTH-dependent Cushing's syndrome: a comparison with other tests.
    Shi X; Sun Q; Bian L; Zhao W; Shen J; Wang W; Ning G
    Neuro Endocrinol Lett; 2011; 32(6):865-73. PubMed ID: 22286783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regional homogeneity in the patients of irritable bowel syndrome complicated with depression: a resting-state functional magnetic resonance imaging study].
    Li J; Li GX; Guo Y; Lu XQ; Li L; Ding JP
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(3):196-201. PubMed ID: 29374914
    [No Abstract]   [Full Text] [Related]  

  • 24. Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing's syndrome.
    Elias PC; Martinez EZ; Barone BF; Mermejo LM; Castro M; Moreira AC
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2045-51. PubMed ID: 24628557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome.
    Bui F; Macri' C; Varotto L; Boscaro M; Mantero F
    Cardiology; 1985; 72 Suppl 1():76-83. PubMed ID: 2996768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Barbot M; Trementino L; Zilio M; Ceccato F; Albiger N; Daniele A; Frigo AC; Mardari R; Rolma G; Boscaro M; Arnaldi G; Scaroni C
    Pituitary; 2016 Oct; 19(5):488-95. PubMed ID: 27236452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.
    Arnaldi G; Tirabassi G; Papa R; Furlani G; Trementino L; Cardinaletti M; Faloia E; Boscaro M
    Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
    Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
    J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic value of urinary free cortisol in the subclinical Cushing's syndrome in patients with adrenal incidentaloma].
    Li LL; Zhao L; Dou JT; Yang GQ; Gu WJ; Lü ZH; Ba JM; Mu YM
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(46):3632-3635. PubMed ID: 29275606
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.
    Valassi E; Franz H; Brue T; Feelders RA; Netea-Maier R; Tsagarakis S; Webb SM; Yaneva M; Reincke M; Droste M; Komerdus I; Maiter D; Kastelan D; Chanson P; Pfeifer M; Strasburger CJ; Tóth M; Chabre O; Tabarin A; Krsek M; Fajardo C; Bolanowski M; Santos A; Wass JAH; Trainer PJ;
    Eur J Endocrinol; 2017 May; 176(5):613-624. PubMed ID: 28377460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Jung C; Alford FP; Topliss DJ; Burgess JR; Long F; Gome JJ; Stockigt JR; Inder WJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):78-84. PubMed ID: 20039897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands.
    van den Berg G; Frölich M; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3750-7. PubMed ID: 8530629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing's syndrome.
    Machado MC; de Sa SV; Domenice S; Fragoso MC; Puglia P; Pereira MA; de Mendonça BB; Salgado LR
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):136-42. PubMed ID: 17201813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.